Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 220

1.

Effect of Bronchodilation and Exercise Training with Behavior Modification on Exercise Tolerance and Downstream Effects on Symptoms and Physical Activity in COPD.

Troosters T, Maltais F, Leidy N, Lavoie KL, Sedeno M, Janssens W, Garcia-Aymerich J, Erzen D, De Sousa D, Korducki L, Hamilton A, Bourbeau J.

Am J Respir Crit Care Med. 2018 Apr 17. doi: 10.1164/rccm.201706-1288OC. [Epub ahead of print]

PMID:
29664681
2.

Smoke-induced neuromuscular junction degeneration precedes the fibre type shift and atrophy in COPD.

Kapchinsky S, Vuda M, Miguez K, Elkrief D, de Souza AR, Baglole CJ, Aare S, MacMillan NJ, Baril J, Rozakis P, Sonjak V, Pion C, Aubertin-Leheudre M, Morais JA, Jagoe RT, Bourbeau J, Taivassalo T, Hepple RT.

J Physiol. 2018 Apr 16. doi: 10.1113/JP275558. [Epub ahead of print]

PMID:
29663403
3.

Measurement of Atmospheric Neutrino Oscillations at 6-56 GeV with IceCube DeepCore.

Aartsen MG, Ackermann M, Adams J, Aguilar JA, Ahlers M, Ahrens M, Al Samarai I, Altmann D, Andeen K, Anderson T, Ansseau I, Anton G, Argüelles C, Auffenberg J, Axani S, Bagherpour H, Bai X, Barron JP, Barwick SW, Baum V, Bay R, Beatty JJ, Becker Tjus J, Becker KH, BenZvi S, Berley D, Bernardini E, Besson DZ, Binder G, Bindig D, Blaufuss E, Blot S, Bohm C, Börner M, Bos F, Bose D, Böser S, Botner O, Bourbeau J, Bradascio F, Braun J, Brayeur L, Brenzke M, Bretz HP, Bron S, Brostean-Kaiser J, Burgman A, Carver T, Casey J, Casier M, Cheung E, Chirkin D, Christov A, Clark K, Classen L, Coenders S, Collin GH, Conrad JM, Cowen DF, Cross R, Day M, de André JPAM, De Clercq C, DeLaunay JJ, Dembinski H, De Ridder S, Desiati P, de Vries KD, de Wasseige G, de With M, DeYoung T, Díaz-Vélez JC, di Lorenzo V, Dujmovic H, Dumm JP, Dunkman M, Eberhardt B, Ehrhardt T, Eichmann B, Eller P, Evenson PA, Fahey S, Fazely AR, Felde J, Filimonov K, Finley C, Flis S, Franckowiak A, Friedman E, Fuchs T, Gaisser TK, Gallagher J, Gerhardt L, Ghorbani K, Giang W, Glauch T, Glüsenkamp T, Goldschmidt A, Gonzalez JG, Grant D, Griffith Z, Haack C, Hallgren A, Halzen F, Hanson K, Hebecker D, Heereman D, Helbing K, Hellauer R, Hickford S, Hignight J, Hill GC, Hoffman KD, Hoffmann R, Hokanson-Fasig B, Hoshina K, Huang F, Huber M, Hultqvist K, Hünnefeld M, In S, Ishihara A, Jacobi E, Japaridze GS, Jeong M, Jero K, Jones BJP, Kalaczynski P, Kang W, Kappes A, Karg T, Karle A, Katz U, Kauer M, Keivani A, Kelley JL, Kheirandish A, Kim J, Kim M, Kintscher T, Kiryluk J, Kittler T, Klein SR, Kohnen G, Koirala R, Kolanoski H, Köpke L, Kopper C, Kopper S, Koschinsky JP, Koskinen DJ, Kowalski M, Krings K, Kroll M, Krückl G, Kunnen J, Kunwar S, Kurahashi N, Kuwabara T, Kyriacou A, Labare M, Lanfranchi JL, Larson MJ, Lauber F, Lennarz D, Lesiak-Bzdak M, Leuermann M, Liu QR, Lu L, Lünemann J, Luszczak W, Madsen J, Maggi G, Mahn KBM, Mancina S, Maruyama R, Mase K, Maunu R, McNally F, Meagher K, Medici M, Meier M, Menne T, Merino G, Meures T, Miarecki S, Micallef J, Momenté G, Montaruli T, Moore RW, Moulai M, Nahnhauer R, Nakarmi P, Naumann U, Neer G, Niederhausen H, Nowicki SC, Nygren DR, Obertacke Pollmann A, Olivas A, O'Murchadha A, Palczewski T, Pandya H, Pankova DV, Peiffer P, Pepper JA, Pérez de Los Heros C, Pieloth D, Pinat E, Plum M, Price PB, Przybylski GT, Raab C, Rädel L, Rameez M, Rawlins K, Rea IC, Reimann R, Relethford B, Relich M, Resconi E, Rhode W, Richman M, Robertson S, Rongen M, Rott C, Ruhe T, Ryckbosch D, Rysewyk D, Sälzer T, Sanchez Herrera SE, Sandrock A, Sandroos J, Sarkar S, Sarkar S, Satalecka K, Schlunder P, Schmidt T, Schneider A, Schoenen S, Schöneberg S, Schumacher L, Seckel D, Seunarine S, Soedingrekso J, Soldin D, Song M, Spiczak GM, Spiering C, Stachurska J, Stamatikos M, Stanev T, Stasik A, Stettner J, Steuer A, Stezelberger T, Stokstad RG, Stößl A, Strotjohann NL, Sullivan GW, Sutherland M, Taboada I, Tatar J, Tenholt F, Ter-Antonyan S, Terliuk A, Tešić G, Tilav S, Toale PA, Tobin MN, Toscano S, Tosi D, Tselengidou M, Tung CF, Turcati A, Turley CF, Ty B, Unger E, Usner M, Vandenbroucke J, Van Driessche W, van Eijndhoven N, Vanheule S, van Santen J, Vehring M, Vogel E, Vraeghe M, Walck C, Wallace A, Wallraff M, Wandler FD, Wandkowsky N, Waza A, Weaver C, Weiss MJ, Wendt C, Werthebach J, Westerhoff S, Whelan BJ, Wiebe K, Wiebusch CH, Wille L, Williams DR, Wills L, Wolf M, Wood J, Wood TR, Woolsey E, Woschnagg K, Xu DL, Xu XW, Xu Y, Yanez JP, Yodh G, Yoshida S, Yuan T, Zoll M; IceCube Collaboration.

Phys Rev Lett. 2018 Feb 16;120(7):071801. doi: 10.1103/PhysRevLett.120.071801.

PMID:
29542976
4.

Effect of Inhaled Nebulized Furosemide (40 and 120 mg) on Breathlessness during Exercise in the Presence of External Thoracic Restriction in Healthy Men.

Waskiw-Ford M, Wu A, Mainra A, Marchand N, Alhuzaim A, Bourbeau J, Smith BM, Jensen D.

Front Physiol. 2018 Feb 12;9:86. doi: 10.3389/fphys.2018.00086. eCollection 2018.

5.

Development of a patient-centred, evidence-based and consensus-based discharge care bundle for patients with acute exacerbation of chronic obstructive pulmonary disease.

Ospina MB, Michas M, Deuchar L, Leigh R, Bhutani M, Rowe BH, Marciniuk D, Goodridge D, Dechman G, Bourbeau J, Balter M, Camp P, Hernandez P, Goldstein RS, Stickland MK.

BMJ Open Respir Res. 2018 Jan 30;5(1):e000265. doi: 10.1136/bmjresp-2017-000265. eCollection 2018.

6.

Health Services Burden of Undiagnosed and Overdiagnosed COPD.

Gershon AS, Thiruchelvam D, Chapman KR, Aaron SD, Stanbrook MB, Bourbeau J, Tan W, To T; Canadian Respiratory Research Network.

Chest. 2018 Feb 6. pii: S0012-3692(18)30238-1. doi: 10.1016/j.chest.2018.01.038. [Epub ahead of print]

PMID:
29425675
7.

The New "Opioid Crisis": Scientific Bias, Media Attention, and Potential Harms for Patients with Refractory Dyspnea.

Rocker G, Bourbeau J, Downar J.

J Palliat Med. 2018 Feb;21(2):120-122. doi: 10.1089/jpm.2017.0619. No abstract available.

PMID:
29393775
8.

COMET: a multicomponent home-based disease-management programme versus routine care in severe COPD.

Kessler R, Casan-Clara P, Koehler D, Tognella S, Viejo JL, Dal Negro RW, Díaz-Lobato S, Reissig K, Rodríguez González-Moro JM, Devouassoux G, Chavaillon JM, Botrus P, Arnal JM, Ancochea J, Bergeron-Lafaurie A, De Abajo C, Randerath WJ, Bastian A, Cornelissen CG, Nilius G, Texereau JB, Bourbeau J.

Eur Respir J. 2018 Jan 11;51(1). pii: 1701612. doi: 10.1183/13993003.01612-2017. Print 2018 Jan.

PMID:
29326333
9.

Self-management strategies in chronic obstructive pulmonary disease: a first step toward personalized medicine.

Barrecheguren M, Bourbeau J.

Curr Opin Pulm Med. 2018 Mar;24(2):191-198. doi: 10.1097/MCP.0000000000000460.

PMID:
29278544
10.

Investigating fractional exhaled nitric oxide (FeNO) in chronic obstructive pulmonary disease (COPD) and asthma-COPD overlap (ACO): a scoping review protocol.

Mostafavi-Pour-Manshadi SM, Naderi N, Barrecheguren M, Dehghan A, Bourbeau J.

BMJ Open. 2017 Dec 21;7(12):e018954. doi: 10.1136/bmjopen-2017-018954.

11.

Effect of morphine on breathlessness and exercise endurance in advanced COPD: a randomised crossover trial.

Abdallah SJ, Wilkinson-Maitland C, Saad N, Li PZ, Smith BM, Bourbeau J, Jensen D.

Eur Respir J. 2017 Oct 19;50(4). pii: 1701235. doi: 10.1183/13993003.01235-2017. Print 2017 Oct.

PMID:
29051274
12.

Work productivity loss in mild to moderate COPD: lessons learned from the CanCOLD study.

de Sousa Sena R, Ahmed S, Tan WC, Li PZ, Labonté L, Aaron SD, Benedetti A, Chapman KR, Walker B, Fitzgerald JM, Hernandez P, Maltais F, Marciniuk DD, O'Donnell DE, Sin DD, Bourbeau J; CanCOLD Collaborative Research Group and The Canadian Respiratory Research Network.

Eur Respir J. 2017 Sep 12;50(3). pii: 1701154. doi: 10.1183/13993003.01154-2017. Print 2017 Sep. No abstract available.

PMID:
28899939
13.

Total Airway Count on Computed Tomography and the Risk of Chronic Obstructive Pulmonary Disease Progression. Findings from a Population-based Study.

Kirby M, Tanabe N, Tan WC, Zhou G, Obeidat M, Hague CJ, Leipsic J, Bourbeau J, Sin DD, Hogg JC, Coxson HO; CanCOLD Collaborative Research Group; Canadian Respiratory Research Network; CanCOLD Collaborative Research Group, the Canadian Respiratory Research Network.

Am J Respir Crit Care Med. 2018 Jan 1;197(1):56-65. doi: 10.1164/rccm.201704-0692OC.

PMID:
28886252
14.

Global Initiative for Chronic Obstructive Lung Disease 2017 Classification and Lung Function Decline in Chronic Obstructive Pulmonary Disease.

Tan WC, Bourbeau J, Aaron SD, Zhou G, Maltais F, Hernandez P, Fitzgerald JM, Marciniuk DD, Walker BL, Sin DD.

Am J Respir Crit Care Med. 2018 Mar 1;197(5):670-673. doi: 10.1164/rccm.201706-1154LE. No abstract available.

PMID:
28858570
15.

A Novel Method of Estimating Small Airway Disease Using Inspiratory-to-Expiratory Computed Tomography.

Kirby M, Yin Y, Tschirren J, Tan WC, Leipsic J, Hague CJ, Bourbeau J, Sin DD, Hogg JC, Coxson HO; CanCOLD Collaborative Research Group and the Canadian Respiratory Research Network.

Respiration. 2017;94(4):336-345. doi: 10.1159/000478865. Epub 2017 Aug 23.

PMID:
28848199
16.

Telehealth pulmonary rehabilitation: A review of the literature and an example of a nationwide initiative to improve the accessibility of pulmonary rehabilitation.

Selzler AM, Wald J, Sedeno M, Jourdain T, Janaudis-Ferreira T, Goldstein R, Bourbeau J, Stickland MK.

Chron Respir Dis. 2018 Feb;15(1):41-47. doi: 10.1177/1479972317724570. Epub 2017 Aug 8.

17.

The Quebec Respiratory Health Education Network: Integrating a model of self-management education in COPD primary care.

Bourbeau J, Farias R, Li PZ, Gauthier G, Battisti L, Chabot V, Beauchesne MF, Villeneuve D, Côté P, Boulet LP.

Chron Respir Dis. 2017 Jan 1:1479972317723237. doi: 10.1177/1479972317723237. [Epub ahead of print]

PMID:
28750556
18.

Erratum to "Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary" [Arch Bronconeumol. 2017;53:128-49].

Vogelmeier CF, Criner GJ, Martínez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DMG, Varela MVL, Nishimura M, Roche N, Rodríguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agustí A.

Arch Bronconeumol. 2017 Jul;53(7):411-412. doi: 10.1016/j.arbres.2017.06.001. English, Spanish. No abstract available.

19.

Integrating the care of the complex COPD patient.

Donner CF, Carrozzi L, Maio S, Baldacci S, Pistelli F, Viegi G, Purro A, Torchio R, Clini E, Amaducci S, ZuWallack RL, Goldstein R, Morgan M, Bourbeau J, Vagheggini G, Wouters EFM.

Monaldi Arch Chest Dis. 2017 May 18;87(1):786. doi: 10.4081/monaldi.2017.786.

20.

Abdominal Binding Improves Neuromuscular Efficiency of the Human Diaphragm during Exercise.

Abdallah SJ, Chan DS, Glicksman R, Mendonca CT, Luo Y, Bourbeau J, Smith BM, Jensen D.

Front Physiol. 2017 May 31;8:345. doi: 10.3389/fphys.2017.00345. eCollection 2017.

21.

Eccentric Ergometer Training Promotes Locomotor Muscle Strength but Not Mitochondrial Adaptation in Patients with Severe Chronic Obstructive Pulmonary Disease.

MacMillan NJ, Kapchinsky S, Konokhova Y, Gouspillou G, de Sousa Sena R, Jagoe RT, Baril J, Carver TE, Andersen RE, Richard R, Perrault H, Bourbeau J, Hepple RT, Taivassalo T.

Front Physiol. 2017 Mar 3;8:114. doi: 10.3389/fphys.2017.00114. eCollection 2017.

22.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.

Vogelmeier CF, Criner GJ, Martínez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, López Varela MV, Nishimura M, Roche N, Rodríguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agustí A.

Arch Bronconeumol. 2017 Mar;53(3):128-149. doi: 10.1016/j.arbres.2017.02.001. Epub 2017 Mar 6. English, Spanish. Erratum in: Arch Bronconeumol. 2017 Jul;53(7):411-412.

23.

Diagnostic Instability and Reversals of Chronic Obstructive Pulmonary Disease Diagnosis in Individuals with Mild to Moderate Airflow Obstruction.

Aaron SD, Tan WC, Bourbeau J, Sin DD, Loves RH, MacNeil J, Whitmore GA; Canadian Respiratory Research Network.

Am J Respir Crit Care Med. 2017 Aug 1;196(3):306-314. doi: 10.1164/rccm.201612-2531OC.

PMID:
28267373
24.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.

Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, López Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agusti A.

Eur Respir J. 2017 Mar 6;49(3). pii: 1700214. doi: 10.1183/13993003.00214-2017. Print 2017 Mar. Erratum in: Eur Respir J. 2017 Jun 22;49(6):.

PMID:
28182564
25.

Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.

Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, López Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agusti A.

Respirology. 2017 Apr;22(3):575-601. doi: 10.1111/resp.13012. Epub 2017 Mar 7.

26.

Evaluating the risk of pneumonia with inhaled corticosteroids in COPD: Retrospective database studies have their limitations SA.

Bourbeau J, Aaron SD, Barnes NC, Davis KJ, Lacasse Y, Nadeau G.

Respir Med. 2017 Feb;123:94-97. doi: 10.1016/j.rmed.2016.12.015. Epub 2016 Dec 23. Review.

27.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.

Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, López Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agustí A.

Am J Respir Crit Care Med. 2017 Mar 1;195(5):557-582. doi: 10.1164/rccm.201701-0218PP.

28.

Multi-center, randomized, placebo-controlled trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease: a study protocol for the INOX trial.

Lacasse Y, Bernard S, Sériès F, Nguyen VH, Bourbeau J, Aaron S, Maltais F; International Nocturnal Oxygen (INOX) Research Group.

BMC Pulm Med. 2017 Jan 9;17(1):8. doi: 10.1186/s12890-016-0343-9.

29.

Bronchodilator Response in FVC Is Larger and More Relevant Than in FEV1 in Severe Airflow Obstruction.

Quanjer PH, Ruppel GL, Langhammer A, Krishna A, Mertens F, Johannessen A, Menezes AMB, Wehrmeister FC, Perez-Padilla R, Swanney MP, Tan WC, Bourbeau J.

Chest. 2017 May;151(5):1088-1098. doi: 10.1016/j.chest.2016.12.017. Epub 2016 Dec 28.

PMID:
28040521
30.

Three-minute constant rate step test for detecting exertional dyspnea relief after bronchodilation in COPD.

Borel B, Wilkinson-Maitland CA, Hamilton A, Bourbeau J, Perrault H, Jensen D, Maltais F.

Int J Chron Obstruct Pulmon Dis. 2016 Nov 29;11:2991-3000. eCollection 2016.

31.

Findings on Thoracic Computed Tomography Scans and Respiratory Outcomes in Persons with and without Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study.

Tan WC, Hague CJ, Leipsic J, Bourbeau J, Zheng L, Li PZ, Sin DD, Coxson HO, Kirby M, Hogg JC, Raju R, Road J, O'Donnell DE, Maltais F, Hernandez P, Cowie R, Chapman KR, Marciniuk DD, FitzGerald JM, Aaron SD; Canadian Respiratory Research Network and the CanCOLD Collaborative Research group.

PLoS One. 2016 Nov 18;11(11):e0166745. doi: 10.1371/journal.pone.0166745. eCollection 2016.

32.
33.

Rebuttal: Should primary care guidelines be written by family physicians? NO.

Bourbeau J.

Can Fam Physician. 2016 Sep;62(9):e505. No abstract available.

34.

[Les lignes directrices en soins primaires devraient-elles être rédigées par des médecins de famille? NON].

Bourbeau J.

Can Fam Physician. 2016 Sep;62(9):710-1. French. No abstract available.

35.

Should primary care guidelines be written by family physicians? NO.

Bourbeau J.

Can Fam Physician. 2016 Sep;62(9):706-7. No abstract available.

36.

Health Coaching: Another Component of Personalized Medicine for Patients with Chronic Obstructive Pulmonary Disease.

Roche N, Bourbeau J.

Am J Respir Crit Care Med. 2016 Sep 15;194(6):647-9. doi: 10.1164/rccm.201604-0696ED. No abstract available.

PMID:
27628071
37.

Do self-management interventions in COPD patients work and which patients benefit most? An individual patient data meta-analysis.

Jonkman NH, Westland H, Trappenburg JC, Groenwold RH, Bischoff EW, Bourbeau J, Bucknall CE, Coultas D, Effing TW, Epton MJ, Gallefoss F, Garcia-Aymerich J, Lloyd SM, Monninkhof EM, Nguyen HQ, van der Palen J, Rice KL, Sedeno M, Taylor SJ, Troosters T, Zwar NA, Hoes AW, Schuurmans MJ.

Int J Chron Obstruct Pulmon Dis. 2016 Aug 31;11:2063-74. doi: 10.2147/COPD.S107884. eCollection 2016.

38.

Cross-Cultural Adaptation of the CHAMPS Questionnaire in French Canadians with COPD.

Mak S, Soicher JE, Mayo NE, Wood-Dauphinee S, Bourbeau J.

Can Respir J. 2016;2016:9304505. doi: 10.1155/2016/9304505. Epub 2016 May 31.

39.

An international randomized study of a home-based self-management program for severe COPD: the COMET.

Bourbeau J, Casan P, Tognella S, Haidl P, Texereau JB, Kessler R.

Int J Chron Obstruct Pulmon Dis. 2016 Jun 28;11:1447-51. doi: 10.2147/COPD.S107151. eCollection 2016.

40.

The COPD Assessment Test: Can It Discriminate Across COPD Subpopulations?

Gupta N, Pinto L, Benedetti A, Li PZ, Tan WC, Aaron SD, Chapman KR, FitzGerald JM, Hernandez P, Marciniuk DD, Maltais F, O'Donnell DE, Sin D, Walker BL, Bourbeau J; Canadian Respiratory Research Network and the CanCOLD Collaborative Research Group.

Chest. 2016 Nov;150(5):1069-1079. doi: 10.1016/j.chest.2016.06.016. Epub 2016 Jun 27.

PMID:
27364603
41.

High Oxygen Delivery to Preserve Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib. Methodology of the HOPE-IPF Study.

Ryerson CJ, Camp PG, Eves ND, Schaeffer M, Syed N, Dhillon S, Jensen D, Maltais F, O'Donnell DE, Raghavan N, Roman M, Stickland MK, Assayag D, Bourbeau J, Dion G, Fell CD, Hambly N, Johannson KA, Kalluri M, Khalil N, Kolb M, Manganas H, Morán-Mendoza O, Provencher S, Ramesh W, Rolf JD, Wilcox PG, Guenette JA.

Ann Am Thorac Soc. 2016 Sep;13(9):1640-7. doi: 10.1513/AnnalsATS.201604-267OC.

PMID:
27348402
42.

Factors associated with undiagnosed and overdiagnosed COPD.

Gershon AS, Hwee J, Chapman KR, Aaron SD, O'Donnell DE, Stanbrook MB, Bourbeau J, Tan W, Su J, Victor JC, To T.

Eur Respir J. 2016 Aug;48(2):561-4. doi: 10.1183/13993003.00458-2016. Epub 2016 Jun 23. No abstract available.

43.

Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective.

Han MK, Martinez CH, Au DH, Bourbeau J, Boyd CM, Branson R, Criner GJ, Kalhan R, Kallstrom TJ, King A, Krishnan JA, Lareau SC, Lee TA, Lindell K, Mannino DM, Martinez FJ, Meldrum C, Press VG, Thomashow B, Tycon L, Sullivan JL, Walsh J, Wilson KC, Wright J, Yawn B, Zueger PM, Bhatt SP, Dransfield MT.

Lancet Respir Med. 2016 Jun;4(6):473-526. doi: 10.1016/S2213-2600(16)00094-1. Epub 2016 May 13. Review.

PMID:
27185520
44.

Characteristics of effective self-management interventions in patients with COPD: individual patient data meta-analysis.

Jonkman NH, Westland H, Trappenburg JC, Groenwold RH, Bischoff EW, Bourbeau J, Bucknall CE, Coultas D, Effing TW, Epton M, Gallefoss F, Garcia-Aymerich J, Lloyd SM, Monninkhof EM, Nguyen HQ, van der Palen J, Rice KL, Sedeno M, Taylor SJ, Troosters T, Zwar NA, Hoes AW, Schuurmans MJ.

Eur Respir J. 2016 Jul;48(1):55-68. doi: 10.1183/13993003.01860-2015. Epub 2016 Apr 28.

45.

Definition of a COPD self-management intervention: International Expert Group consensus.

Effing TW, Vercoulen JH, Bourbeau J, Trappenburg J, Lenferink A, Cafarella P, Coultas D, Meek P, van der Valk P, Bischoff EW, Bucknall C, Dewan NA, Early F, Fan V, Frith P, Janssen DJ, Mitchell K, Morgan M, Nici L, Patel I, Walters H, Rice KL, Singh S, Zuwallack R, Benzo R, Goldstein R, Partridge MR, van der Palen J.

Eur Respir J. 2016 Jul;48(1):46-54. doi: 10.1183/13993003.00025-2016. Epub 2016 Apr 13.

46.

Enhancing exercise tolerance and physical activity in COPD with combined pharmacological and non-pharmacological interventions: PHYSACTO randomised, placebo-controlled study design.

Troosters T, Bourbeau J, Maltais F, Leidy N, Erzen D, De Sousa D, Korducki L, Hamilton A.

BMJ Open. 2016 Apr 13;6(4):e010106. doi: 10.1136/bmjopen-2015-010106.

47.

The Unmet Educational Needs of Patients with Interstitial Lung Disease. Setting the Stage for Tailored Pulmonary Rehabilitation.

Morisset J, Dubé BP, Garvey C, Bourbeau J, Collard HR, Swigris JJ, Lee JS.

Ann Am Thorac Soc. 2016 Jul;13(7):1026-33. doi: 10.1513/AnnalsATS.201512-836OC.

PMID:
27064659
48.

Behaviour-change intervention in a multicentre, randomised, placebo-controlled COPD study: methodological considerations and implementation.

Bourbeau J, Lavoie KL, Sedeno M, De Sousa D, Erzen D, Hamilton A, Maltais F, Troosters T, Leidy N.

BMJ Open. 2016 Apr 4;6(4):e010109. doi: 10.1136/bmjopen-2015-010109.

49.

Club Cell-16 and RelB as Novel Determinants of Arterial Stiffness in Exacerbating COPD Patients.

Labonté LE, Bourbeau J, Daskalopoulou SS, Zhang M, Coulombe P, Garland K, Baglole CJ.

PLoS One. 2016 Feb 25;11(2):e0149974. doi: 10.1371/journal.pone.0149974. eCollection 2016.

50.

Failed upregulation of TFAM protein and mitochondrial DNA in oxidatively deficient fibers of chronic obstructive pulmonary disease locomotor muscle.

Konokhova Y, Spendiff S, Jagoe RT, Aare S, Kapchinsky S, MacMillan NJ, Rozakis P, Picard M, Aubertin-Leheudre M, Pion CH, Bourbeau J, Hepple RT, Taivassalo T.

Skelet Muscle. 2016 Feb 18;6:10. doi: 10.1186/s13395-016-0083-9. eCollection 2016.

Supplemental Content

Loading ...
Support Center